In a groundbreaking move signaling the growing acceptance of digital assets in corporate finance, Nasdaq-listed BioNexus Gene Lab has announced its adoption of Ethereum as its primary treasury asset. This bold decision, revealed by Unfolded on X, is further substantiated by the release of an Ethereu...